All articles by Vidya Sagar
Vidya Sagar
Medtronic’s PulseSelect PFA System shows positive results in FDA IDE trial
US-based healthcare technology Medtronic has announced positive results for its PulseSelect Pulsed Field Ablation (PFA) System from a clinical study,…
Masimo and Temple Health Form Innovation Collaboration with Focus on Hospital Automation and Telehealth Initiatives
Masimo (NASDAQ: MASI), a leading global provider of medical technology and automation solutions, and Temple Health, Philadelphia’s 979-bed academic health system, announced…
Sooma secures FDA Breakthrough Designation for depression therapy device
Finland-based Sooma Medical has received the US Food and Drug Administration (FDA) Breakthrough Device designation for its portable, at-home neuromodulation…
Abbott announces positive study results for Triclip system and MitraClip therapy
Abbott announced that its TriClip transcatheter edge-to-edge repair (TEER) system is superior to medical therapy in treating patients with tricuspid…
AffaMed Technologies Announces the First Implantation in the China Registrational Clinical Trial of MINI WELL
AffaMed Technologies (“AffaMed”), a joint venture established between AffaMed Therapeutics and SIFI S.p.A., today announced the completion of the first…
Illumina, Myriad expand partnership to boost HRD testing in US
US-based DNA sequencing company Illumina and genetic testing company Myriad Genetics have extended their partnership to improve the access to…
Noah Medical receives FDA approval for Galaxy System for bronchoscopy
US-based medical robotics manufacturer Noah Medical has received the Food and Drug Administration (FDA) approval for its Galaxy System. The…
Bigfoot Biomedical Receives FDA Clearance for Bigfoot Unity Android App for People Living with Insulin-Requiring Diabetes
Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced the U.S. Food and Drug Administration (FDA)…
GE HealthCare completes patient recruitment in manganese-based MRI agent study
GE HealthCare has completed patient recruitment in the Phase 1 clinical trial programme for its manganese-based macrocyclic magnetic resonance imaging…
SpectraWAVE receives FDA approval for HyperVue intravascular imaging system
US-based medical equipment manufacturer SpectraWAVE has received the US Food and Drug Administration (FDA) 510(k) approval for its HyperVue intravascular…